PARNAX LAB
Back to Income Statement
|
PARNAX LAB Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹9.61 Cr | ₹8.62 Cr | ₹824 Cr | ₹-0.36 Cr | ₹-2.91 Cr |
What is the latest Consolidated Net Profit of PARNAX LAB ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹9.61 Cr |
| Mar2024 | ₹8.62 Cr |
| Mar2023 | ₹824 Cr |
| Mar2022 | ₹-0.36 Cr |
| Mar2021 | ₹-2.91 Cr |
How is Consolidated Net Profit of PARNAX LAB Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.61 Cr | 11.50 | |
| Mar2024 | ₹8.62 Cr | -98.95 | |
| Mar2023 | ₹824 Cr | Positive | |
| Mar2022 | ₹-0.36 Cr | Negative | |
| Mar2021 | ₹-2.91 Cr | - | |
Compare Consolidated Net Profit of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹153.1 Cr | 8.5% | 2.4% | 44.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 8.5% |
2.4% |
44.9% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses